• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Okta Shares Are Trading Higher By 11%; Here Are 20 Stocks Moving Premarket

    8/31/23 8:13:35 AM ET
    $AGIL
    $ALLR
    $AXLA
    $BENF
    Professional Services
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AGIL alert in real time by email

    Gainers

    • iCoreConnect Inc. (OTC:ICCT) rose 88% to $23.09 in pre-market trading after jumping 119% on Wednesday. Last Friday, the company announced theclosing of its previously announced business combination with FG Merger Corp., a special purpose acquisition corporation (SPAC).
    • noco-noco Inc. (NASDAQ:NCNC) shares gained 55% to $2.47 in pre-market trading after falling 20% on Wednesday.
    • Allarity Therapeutics, Inc. (NASDAQ:ALLR) shares climbed 37% to $2.22 in pre-market trading after the company announced the publication of its clinical validation of a novel drug-specific DRP®-companion diagnostic for dovitinib in the peer-reviewed journal PLOS ONE.
    • Infobird Co., Ltd (NASDAQ:IFBD) shares rose 35% to $0.3780 in pre-market trading after gaining 11% on Wednesday.
    • Verde Clean Fuels, Inc. (NASDAQ:VGAS) shares rose 26.1% to $5.65 in pre-market trading.
    • NLS Pharmaceutics AG (NASDAQ:NLSP) rose 17% to $1.17 in pre-market trading after gaining around 8% on Wednesday.
    • Treasure Global Inc. (NYSE:TGL) shares gained 14.5% to $0.4501 in pre-market trading.
    • Better Home & Finance Holding Company (NASDAQ:BETR) shares jumped 12.6% to $0.9795 in pre-market trading.
    • Lixiang Education Holding Co., Ltd. (NASDAQ:LXEH) gained 12.3% to $0.4076 in pre-market trading after falling over 15% on Wednesday.
    • Okta, Inc. (NASDAQ:OKTA) shares surged 11% to $81.65 in pre-market trading after the company reported better-than-expected second-quarter financial results and raised FY24 guidance above estimates.

    Losers

    • Axcella Health Inc. (NASDAQ:AXLA) fell 20.1% to $0.3049 in pre-market trading after falling 15% on Wednesday.
    • Digital Brands Group, Inc. (NASDAQ:DBGI) fell 12% to $10.01 in pre-market trading after jumping 35% on Wednesday.
    • AgileThought, Inc. (NASDAQ:AGIL) shares fell 11.1% to $0.2522 in pre-market trading after jumping 83% on Wednesday.
    • Beneficient (NASDAQ:BENF) fell 10.7% to $2.39 in pre-market trading after surging 28% on Wednesday
    • Top KingWin Ltd (NASDAQ:TCJH) shares fell 10.7% to $1.34 in pre-market trading after gaining 15% on Wednesday.
    • OKYO Pharma Limited (NASDAQ:OKYO) fell 10.4% to $2.24 in pre-market trading after dipping 18% on Wednesday. The company announced that it has enrolled and randomized 90% of the patients in its 240-patient Phase 2 clinical trial of OK-101 to treat dry eye disease.
    • Hillstream BioPharma, Inc. (NASDAQ:HILS) fell 9.2% to $0.2195 in pre-market.
    • WANG & LEE GROUP, Inc. (NASDAQ:WLGS) fell 8.7% to $0.8117 in pre-market trading after gaining over 5% on Wednesday.
    • ReTo Eco-Solutions, Inc. (NASDAQ:RETO) fell 8.6% to $0.9684 in pre-market trading after jumping 34% on Wednesday.
    • CION Investment Corporation (NYSE:CION) shares fell 7.5% to $10.00 in pre-market trading.

     

    Now Read This: Investor Optimism Improves Further As Investors Assess Economic Reports

    Get the next $AGIL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGIL
    $ALLR
    $AXLA
    $BENF

    CompanyDatePrice TargetRatingAnalyst
    Okta Inc.
    $OKTA
    3/19/2026$100.00Outperform
    Macquarie
    Okta Inc.
    $OKTA
    3/6/2026$97.00Market Perform → Outperform
    BMO Capital Markets
    Okta Inc.
    $OKTA
    3/3/2026$76.00Equal Weight
    Wells Fargo
    Okta Inc.
    $OKTA
    2/26/2026$90.00 → $83.00Market Perform
    BMO Capital Markets
    OKYO Pharma Limited
    $OKYO
    2/20/2026$7.00Overweight
    Piper Sandler
    Okta Inc.
    $OKTA
    1/14/2026$120.00Equal-Weight → Overweight
    Stephens
    Okta Inc.
    $OKTA
    12/16/2025$125.00Hold → Buy
    Jefferies
    OKYO Pharma Limited
    $OKYO
    12/8/2025$5.00Buy
    B. Riley Securities
    More analyst ratings

    $AGIL
    $ALLR
    $AXLA
    $BENF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Addison Jonathan James

    4 - Okta, Inc. (0001660134) (Issuer)

    3/27/26 5:05:14 PM ET
    $OKTA
    Computer Software: Prepackaged Software
    Technology

    SEC Form 3 filed by new insider Chen Zhihua

    3 - Infobird Co., Ltd (0001815566) (Issuer)

    3/26/26 8:35:16 AM ET
    $IFBD
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Garg Vishal

    4 - Better Home & Finance Holding Co (0001835856) (Issuer)

    3/25/26 5:48:22 PM ET
    $BETR
    Finance: Consumer Services
    Finance

    $AGIL
    $ALLR
    $AXLA
    $BENF
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Macquarie initiated coverage on Okta with a new price target

    Macquarie initiated coverage of Okta with a rating of Outperform and set a new price target of $100.00

    3/19/26 8:26:35 AM ET
    $OKTA
    Computer Software: Prepackaged Software
    Technology

    Okta upgraded by BMO Capital Markets with a new price target

    BMO Capital Markets upgraded Okta from Market Perform to Outperform and set a new price target of $97.00

    3/6/26 8:20:09 AM ET
    $OKTA
    Computer Software: Prepackaged Software
    Technology

    Wells Fargo initiated coverage on Okta with a new price target

    Wells Fargo initiated coverage of Okta with a rating of Equal Weight and set a new price target of $76.00

    3/3/26 8:28:32 AM ET
    $OKTA
    Computer Software: Prepackaged Software
    Technology

    $AGIL
    $ALLR
    $AXLA
    $BENF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Framework Ventures Iv L.P. bought $738,750 worth of shares (25,000 units at $29.55) (SEC Form 4)

    4 - Better Home & Finance Holding Co (0001835856) (Issuer)

    3/16/26 8:04:38 PM ET
    $BETR
    Finance: Consumer Services
    Finance

    Large owner Framework Ventures Iv L.P. bought $1,006,335 worth of shares (29,494 units at $34.12) (SEC Form 4)

    4 - Better Home & Finance Holding Co (0001835856) (Issuer)

    3/13/26 7:09:54 PM ET
    $BETR
    Finance: Consumer Services
    Finance

    Large owner Framework Ventures Iv L.P. bought $1,212,689 worth of shares (31,598 units at $38.38) and exercised 211,312 in-the-money shares at a strike of $27.12 (SEC Form 4)

    4 - Better Home & Finance Holding Co (0001835856) (Issuer)

    3/11/26 9:23:33 PM ET
    $BETR
    Finance: Consumer Services
    Finance

    $AGIL
    $ALLR
    $AXLA
    $BENF
    SEC Filings

    View All

    SEC Form 10-K filed by Verde Clean Fuels Inc.

    10-K - Verde Clean Fuels, Inc. (0001841425) (Filer)

    3/27/26 4:48:55 PM ET
    $VGAS
    Major Chemicals
    Industrials

    Verde Clean Fuels Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Verde Clean Fuels, Inc. (0001841425) (Filer)

    3/27/26 4:41:45 PM ET
    $VGAS
    Major Chemicals
    Industrials

    Amendment: SEC Form SCHEDULE 13G/A filed by Okta Inc.

    SCHEDULE 13G/A - Okta, Inc. (0001660134) (Subject)

    3/27/26 11:03:58 AM ET
    $OKTA
    Computer Software: Prepackaged Software
    Technology

    $AGIL
    $ALLR
    $AXLA
    $BENF
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Verde Clean Fuels, Inc. Reports Q4 and FY 2025 Results

    Verde Clean Fuels, Inc. ("Verde" or the "Company") (NASDAQ:VGAS) announced today financial results for the fourth quarter and full year 2025. "We remain focused on our revised strategy to deploy our technology while remaining extremely disciplined with our resources. Related to our revised strategy, we are also continuing to evaluate strategic alternatives that may be available to us, including a potential sale or merger," said George Burdette, CEO of Verde. The Company ended the year 2025 with $57.2 million of cash and cash equivalents and no debt. For the fourth quarter 2025, the Company recorded a net loss of $(6.6) million and diluted net loss per share of Class A common stock of

    3/27/26 4:15:00 PM ET
    $VGAS
    Major Chemicals
    Industrials

    Treasure Global Reports 7x ARPU Growth on ZCITY; TAZTE Enters Strategic Redevelopment

    KUALA LUMPUR, Malaysia, March 26, 2026 (GLOBE NEWSWIRE) -- Treasure Global Inc. (NASDAQ:TGL) ("Treasure Global" or the "Company"), a Southeast Asia–anchored technology company, today announced record engagement and monetization on its ZCITY Super App platform, alongside a strategic redevelopment of its TAZTE platform to strengthen its digital ecosystem. ZCITY Delivers Record Engagement and MonetizationFor the quarter ended December 2025: High-frequency users: 70.1% of paid users completed three or more transactions, up from 43.9% in the prior quarterARPU growth: 7x quarter-over-quarter increaseRegistered users: 2.71 millionRegistered merchants: 2,000+ These results reflect stronger enga

    3/26/26 8:33:00 AM ET
    $TGL
    Real Estate

    Better and Coinbase Launch the First Token-Backed, Conforming Mortgage

    By integrating home finance with digital assets, millions of Americans can now achieve their homeownership goals by pledging BTC or USDC without needing to liquidate their holdings or potentially triggering a taxable event1. Better Home & Finance Holding Company (NASDAQ:BETR), and Coinbase (NASDAQ:COIN), today announced a milestone partnership to bring token-backed mortgages to millions of Americans. Token-backed mortgages are originated and serviced by Better, the leading AI-native mortgage originator, and benefit from the same backing of Fannie Mae as other conforming mortgages. Bitcoin (BTC) and USDC pledges are powered by Coinbase, the largest and most trusted cryptocurrency exchange

    3/26/26 8:30:00 AM ET
    $BETR
    $COIN
    Finance: Consumer Services
    Finance

    $AGIL
    $ALLR
    $AXLA
    $BENF
    Leadership Updates

    Live Leadership Updates

    View All

    Better Home & Finance Holding Company Appoints Hugh Frater, Former Fannie Mae CEO and BlackRock Founding Partner, to Board of Directors

    Veteran investor and housing finance leader brings deep capital markets and mortgage experience to support Better's next phase of AI-driven growth through Tinman® AI Platform Better Home & Finance Holding Company (NASDAQ:BETR) ("Better," the "Company," "we" or "our"), the leading AI-powered homeownership company, today announced that Hugh Frater, a founding partner and former managing director of BlackRock and former CEO of Fannie Mae, has been appointed to its Board of Directors, effective March 23, 2026. Frater brings decades of experience across capital markets, housing finance, and corporate leadership to help guide Better's long-term strategy as it scales the Tinman AI Platform. "H

    3/25/26 4:30:00 PM ET
    $BETR
    $HIPO
    Finance: Consumer Services
    Finance
    Property-Casualty Insurers

    Verde Clean Fuels, Inc. Announces New CEO and Engagement of Financial Advisor to Evaluate Strategic Alternatives

    George Burdette, current Chief Financial Officer, appointed Chief Executive Officer Roth Capital Partners retained as financial advisor to evaluate strategic alternatives, including potential merger or sale Verde Clean Fuels, Inc. (NASDAQ:VGAS) ("Verde" or the "Company") announced today the appointment of George Burdette as Chief Executive Officer ("CEO") and engagement of Roth Capital Partners ("Roth") as financial advisor to assist the Company in evaluating strategic alternatives. These announcements are part of the Company's continued advancement of its previously announced restructuring and cost reduction initiatives. Mr. Burdette succeeds Ernie Miller who is stepping down from h

    3/20/26 6:13:00 PM ET
    $FSLR
    $VGAS
    Semiconductors
    Technology
    Major Chemicals
    Industrials

    Beneficient Appoints Mack H. Hicks to Board of Directors

    DALLAS, March 12, 2026 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ:BENF), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets, today announced the appointment of Mack H. Hicks as a member of the Company's Board of Directors (the "Board"). Mr. Hicks currently serves as Chief Executive Officer of Hicks Holdings LLC, the Dallas-based family office with operating private equity and real estate investment businesses founded by his late father and private equity pioneer, Thomas O. Hicks, who served as Chairman of the Board of Beneficient until his passing in December of 2025. Mr. Hicks also

    3/12/26 7:30:00 AM ET
    $BENF
    Finance: Consumer Services
    Finance

    $AGIL
    $ALLR
    $AXLA
    $BENF
    Financials

    Live finance-specific insights

    View All

    OKYO Pharma Announces Chairman and Founder Acquires Shares

    LONDON and NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and for inflammatory eye diseases, today announced it has been informed that Panetta Partners Limited, an entity in which Gabriele Cerrone, the Executive Chairman, has a beneficial interest, has acquired 10,119 of the Company's ordinary shares on NASDAQ at $1.59, bringing his total holding to 10,526,416 shares. About Urcosimod (formerly called OK-101) Urcosimod is a lipid conjugated chemerin peptide agonist of the ChemR23 G-protein coupled receptor which is typically

    3/19/26 12:00:00 PM ET
    $OKYO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    OKYO Pharma Announces Director Acquires Shares

    LONDON and NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and for inflammatory eye diseases, today announced it has been informed that John Brancaccio, Non-Executive Director, has acquired 5,000 of the Company's ordinary shares on NASDAQ at $1.61, bringing his total holding to 31,201 shares. About Urcosimod (formerly called OK-101) Urcosimod is a lipid conjugated chemerin peptide agonist of the ChemR23 G-protein coupled receptor which is typically found on immune cells of the eye responsible for the inflammatory response, as

    3/19/26 10:00:00 AM ET
    $OKYO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    OKYO Pharma Announces Chief Development Officer and Director Acquires Shares

    LONDON and NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ:OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and for inflammatory eye diseases, today announced it has been informed that Gary Jacob, Chief Development Officer and Director, has acquired 30,980 of the Company's ordinary shares on NASDAQ at $1.59, bringing his total holding to 108,920 shares. About Urcosimod (formerly called OK-101) Urcosimod is a lipid conjugated chemerin peptide agonist of the ChemR23 G-protein coupled receptor which is typically found on immune cells of the eye responsible for the inflammat

    3/19/26 7:00:00 AM ET
    $OKYO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AGIL
    $ALLR
    $AXLA
    $BENF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Better Home & Finance Holding Company

    SC 13D/A - Better Home & Finance Holding Co (0001835856) (Subject)

    12/17/24 8:40:06 PM ET
    $BETR
    Finance: Consumer Services
    Finance

    Amendment: SEC Form SC 13G/A filed by iCoreConnect Inc.

    SC 13G/A - iCoreConnect Inc. (0001906133) (Subject)

    12/12/24 9:44:00 PM ET
    $ICCT
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by iCoreConnect Inc.

    SC 13G/A - iCoreConnect Inc. (0001906133) (Subject)

    12/5/24 4:08:58 PM ET
    $ICCT
    Computer Software: Prepackaged Software
    Technology